These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2018366)
1. Increased toxicity and DNA cross-linking by peptide bound m-L-sarcolysin (Peptichemio) as compared to melphalan and m-L-sarcolysin in human melanoma cell lines. Lewensohn R; Ehrsson H; Hansson J; Ringborg U Anticancer Res; 1991; 11(1):321-4. PubMed ID: 2018366 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity and DNA cross-linking induced by peptide conjugated m-L-sarcolysin in human melanoma cells. Hansson J; Lewensohn R; Ringborg U Anticancer Res; 1991; 11(5):1725-30. PubMed ID: 1768043 [TBL] [Abstract][Full Text] [Related]
3. Differential DNA cross-linking and cytotoxicity in PHA-stimulated human lymphocytes exposed to melphalan, m-L-sarcolysin and peptichemio. Lewensohn R; Hansson J; Ringborg U; Ehrsson H Eur J Cancer Clin Oncol; 1987 Jun; 23(6):783-8. PubMed ID: 3653195 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients. Larsson R; Dhar S; Ehrsson H; Nygren P; Lewensohn R Br J Cancer; 1998 Aug; 78(3):328-35. PubMed ID: 9703278 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of peptide bound m-L-sarcolysin (peptichemio) on melphalan resistant human myeloma cells in vitro. Lewensohn R; Fernberg JO; Ehrsson H; Merlini G Med Oncol Tumor Pharmacother; 1991; 8(4):265-9. PubMed ID: 1820493 [TBL] [Abstract][Full Text] [Related]
6. In vitro cytotoxicity of peptichemio compared to melphalan and meta-DL-sarcolysin. Morasca L; Erba E Eur J Cancer (1965); 1980 Aug; 16(8):1105-9. PubMed ID: 7439225 [No Abstract] [Full Text] [Related]
7. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells. Hansson J; Edgren M; Ehrsson H; Ringborg U; Nilsson B Cancer Res; 1988 Jan; 48(1):19-26. PubMed ID: 3334994 [TBL] [Abstract][Full Text] [Related]
8. Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide. Roboz J; Jiang J; Holland JF; Bekesi JG Cancer Res; 1997 Nov; 57(21):4795-802. PubMed ID: 9354441 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of the novel melphalan containing tripeptide J3 (L-prolyl-L-melphalanyl-p-L-fluorophenylalanine ethyl ester): comparison with its m-L-sarcolysin analogue P2. Gullbo J; Wallinder C; Tullberg M; Lövborg H; Ehrsson H; Lewensohn R; Nygren P; Luthman K; Larsson R Mol Cancer Ther; 2003 Dec; 2(12):1331-9. PubMed ID: 14707274 [TBL] [Abstract][Full Text] [Related]
10. The effect of the preparation "Peptichemio" on leukopoiesis and experimental tumours of animals compared with that of sarcolysin and thiophosphamide. Balitsky KP; Veksler IG; Tsapenko VF; Kavetsky RE G Ital Chemioter; 1980; 27(1):1-5. PubMed ID: 6793439 [No Abstract] [Full Text] [Related]
11. Different melphalan toxicity and DNA cross-linking in human melanoma cells as compared to phytohaemagglutinin-stimulated lymphocytes. Hansson J; Lewensohn R; Ringborg U Anticancer Res; 1985; 5(5):471-7. PubMed ID: 4062251 [TBL] [Abstract][Full Text] [Related]
12. Effect of alpha-difluoromethylornithine on L-phenylalanine mustard-induced cytotoxicity and DNA interstrand cross-linking in a human cell line in vitro. Ducore JM; McNamara L Cancer Res; 1986 Mar; 46(3):1068-72. PubMed ID: 3080230 [TBL] [Abstract][Full Text] [Related]
13. Melphalan-induced DNA cross-linking in human melanoma cells and phytohaemagglutinin-stimulated lymphocytes in relation to intracellular drug content and cellular levels of glutathione. Hansson J; Edgren M; Ehrsson H; Lewensohn R; Ringborg U Anticancer Res; 1987; 7(1):97-104. PubMed ID: 3566189 [TBL] [Abstract][Full Text] [Related]
14. DNA-damage in human cells treated with the closely related alkylating agents peptichemio, m-L-sarcolysin and melphalan. Ringborg U; Lambert B; Lewensohn R; Turesson I Eur J Cancer Clin Oncol; 1981 Sep; 17(9):991-6. PubMed ID: 7198989 [No Abstract] [Full Text] [Related]
15. Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells. Hansson J; Lewensohn R; Ringborg U; Nilsson B Cancer Res; 1987 May; 47(10):2631-7. PubMed ID: 3567896 [TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid effect on melphalan cytotoxicity, cell-cycle position, cell size, and [3H]uridine incorporation in one of three human melanoma cell lines. Benckhuijsen C; Osman AM; Hillebrand MJ; Smets LA Cancer Res; 1987 Sep; 47(18):4814-20. PubMed ID: 3621177 [TBL] [Abstract][Full Text] [Related]
17. Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustard. Ducore JM; Erickson LC; Zwelling LA; Laurent G; Kohn KW Cancer Res; 1982 Mar; 42(3):897-902. PubMed ID: 7199380 [TBL] [Abstract][Full Text] [Related]
18. L-phenylalanine mustard (melphalan) uptake and cross-linking in the RPMI 6410 human lymphoblastoid cell line. Brox LW; Gowans B; Belch A Cancer Res; 1980 Apr; 40(4):1169-72. PubMed ID: 7357546 [TBL] [Abstract][Full Text] [Related]
19. Melphalan-induced DNA cross-linking and inhibition of DNA and RNA synthesis in human melanoma and lymphoblast cells. Ringborg U; Hansson J; Jungnelius U; Lewensohn R; Skog S Anticancer Res; 1990; 10(2A):297-301. PubMed ID: 2346304 [TBL] [Abstract][Full Text] [Related]
20. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL). Pu Q; Bianchi P; Bezwoda WR Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]